RNS Number : 9267V
Iconic Labs PLC
10 July 2024
 

 

 

Iconic Labs PLC

("Iconic" or the "Company")

Board Changes

Iconic Labs PLC (LSE: ICON) announces that after more than three years of serving as the CEO and a Director of the Company, Brad Taylor is stepping down from all positions with immediate effect.

The Company would like to thank Mr Taylor for his expertise, dedication and professionalism in successfully leading the Company through a complex period of restructuring that included exiting the Company from administration through a Company Voluntary Arrangement (CVA), lifting the suspension of trading on the London Stock Exchange, and entering into negotiations and Heads of Terms with reverse takeover (RTO) target, ITS Holdings 2023 Ltd. 

The Company also announces the appointment of John Farquharson (aged 47) as Interim CEO and Director with immediate effect.  Mr Farquharson has held senior finance roles within the Tavistock Group of companies since 2010 and currently serves as Head of Finance at Ultimate Finance Group Ltd. He graduated from the University of Aberdeen in 1999 with an MA in Accountancy and German following which he worked at PwC from 1999-2004 where he qualified as a chartered accountant in 2002. He is a member of the Institute of Chartered Accountants of Scotland (ICAS) and the Chartered Governance Institute UK and Ireland.

 

- Ends -

 

For more information, please contact:

Iconic Labs

 

John Farquharson

via Yellow Jersey PR

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Charles Goodwin

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEASXEFAFLEFA